Dr. Holger Zinke, CEO of BRAIN AG, during a
panel discussion on the impact of white biotechnology.
(c) BRAIN AG, Zwingenberg – Reprint permitted
with byline
BRAIN – cellular based screening
(c) BRAIN AG, Zwingenberg – Reprint permitted
with byline.
AnalytiCon Discovery
format.
(c) AnalytiCon Discovery
GmbH, Potsdam - Reprint permitted with
byline.
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33